H Pylori Guideline Revision Supplement 2022: Difference between revisions
From Guide to YKHC Medical Practices
mNo edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
<br> | |||
== Reason[s] for update == | == Reason[s] for update == | ||
Routine 2-year update. | Routine 2-year update. | ||
<br> | <br> | ||
<br> | |||
== Methods == | == Methods == | ||
* Review of latest ANMC H. pylori treatment guideline. | * Review of latest ANMC H. pylori treatment guideline ([https://anmc.org/files/CG_HelicobacterPyloriGuideline.pdf Feb 19, 2020 ][https://web.archive.org/web/20201024034528/https://anmc.org/files/CG_HelicobacterPyloriGuideline.pdf , Archive])<br> | ||
* Updated literature search | * Updated literature search (PubMed, [https://pubmed.ncbi.nlm.nih.gov/?term=%28alaska%5BTitle%5D+OR+polar%5BTitle%5D+OR+arctic%5BTitle%5D%29+AND+helicobacter%5BTitle%2FAbstract%5D&sort=date (alaska[Title<nowiki>]</nowiki> OR polar[Title<nowiki>]</nowiki> OR arctic[Title<nowiki>]</nowiki>) AND helicobacter[Title/Abstract<nowiki>]</nowiki>]). This is a broader search than previously in that it looks for "helicobacter" in the abstract as well as the title. | ||
* Attendance at the 2019 Combating Gastric Cancer in Alaska Native People: An Expert and Community Symposium | |||
:: >Hosted by the CDC in Anchorage, Alaska | |||
:: >Experts were longstanding, world-renown researchers | |||
:: >Results were published in ''Gastroenterology'' in April 2020<ref name="Nolen2020">Nolen LD, Vindigni SM, Parsonnet J; Symposium leaders. Combating Gastric Cancer in Alaska Native People: An Expert and Community Symposium. Gastroenterology. 2020 Apr;158(5):1197-1201. doi: 10.1053/j.gastro.2019.11.299. PMID: 31836529; PMCID: [http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7103478/ PMC7103478]. DOI:[https://doi.org/10.1053/j.gastro.2019.11.299 10.1053/j.gastro.2019.11.299]</ref> | |||
<br> | |||
==Results== | |||
# ANMC H. Pylori Treatment Guideline has no significant changes pertinent to the YKHC guideline. Of note, ANMC has started a study of offering EGD for gastric cancer screening for patients with a first-degree relative (parent, sibling, or child) with gastric cancer; they are treating to eradicate H. pylori in this group regardless of findings; but this treatment is limited to the study patients. | |||
# PubMed search returned 49 articles. The only article published since the prior literature search (in 2017) to address treatment in our setting was the CDC conference summary,<ref name="Nolen2020"/> which continues to explicitly advocate the current algorithm/guideline. | |||
<br> | |||
==Guideline Changes== | |||
#Under treatment indications, "Intestinal Metaplasia" is changed to "Gastric Intestinal Metaplasia" to prevent any confusion with Barrett's esophagus. | |||
#Addition of box specifying test of cure details. | |||
<br> | |||
<br> | |||
Author: Andrew W. Swartz, MD | |||
<br> | |||
==References== | |||
---- | |||
Revision as of 00:43, 13 January 2022
Reason[s] for update
Routine 2-year update.
Methods
- Review of latest ANMC H. pylori treatment guideline (Feb 19, 2020 , Archive)
- Updated literature search (PubMed, (alaska[Title] OR polar[Title] OR arctic[Title]) AND helicobacter[Title/Abstract]). This is a broader search than previously in that it looks for "helicobacter" in the abstract as well as the title.
- Attendance at the 2019 Combating Gastric Cancer in Alaska Native People: An Expert and Community Symposium
- >Hosted by the CDC in Anchorage, Alaska
- >Experts were longstanding, world-renown researchers
- >Results were published in Gastroenterology in April 2020[1]
Results
- ANMC H. Pylori Treatment Guideline has no significant changes pertinent to the YKHC guideline. Of note, ANMC has started a study of offering EGD for gastric cancer screening for patients with a first-degree relative (parent, sibling, or child) with gastric cancer; they are treating to eradicate H. pylori in this group regardless of findings; but this treatment is limited to the study patients.
- PubMed search returned 49 articles. The only article published since the prior literature search (in 2017) to address treatment in our setting was the CDC conference summary,[1] which continues to explicitly advocate the current algorithm/guideline.
Guideline Changes
- Under treatment indications, "Intestinal Metaplasia" is changed to "Gastric Intestinal Metaplasia" to prevent any confusion with Barrett's esophagus.
- Addition of box specifying test of cure details.
Author: Andrew W. Swartz, MD
References
- ↑ 1.0 1.1 Nolen LD, Vindigni SM, Parsonnet J; Symposium leaders. Combating Gastric Cancer in Alaska Native People: An Expert and Community Symposium. Gastroenterology. 2020 Apr;158(5):1197-1201. doi: 10.1053/j.gastro.2019.11.299. PMID: 31836529; PMCID: PMC7103478. DOI:10.1053/j.gastro.2019.11.299
